11 found
Order:
Disambiguations
Matthew S. McCoy [6]Matthew McCoy [4]Matthew K. McCoy [1]Matthew Kennedy Mccoy [1]
See also
  1. An Ethical Framework for Global Vaccine Allocation.Ezekiel J. Emanuel, Govind Persad, Adam Kern, Allen E. Buchanan, Cecile Fabre, Daniel Halliday, Joseph Heath, Lisa M. Herzog, R. J. Leland, Ephrem T. Lemango, Florencia Luna, Matthew McCoy, Ole F. Norheim, Trygve Ottersen, G. Owen Schaefer, Kok-Chor Tan, Christopher Heath Wellman, Jonathan Wolff & Henry S. Richardson - 2020 - Science 1:DOI: 10.1126/science.abe2803.
    In this article, we propose the Fair Priority Model for COVID-19 vaccine distribution, and emphasize three fundamental values we believe should be considered when distributing a COVID-19 vaccine among countries: Benefiting people and limiting harm, prioritizing the disadvantaged, and equal moral concern for all individuals. The Priority Model addresses these values by focusing on mitigating three types of harms caused by COVID-19: death and permanent organ damage, indirect health consequences, such as health care system strain and stress, as well as (...)
    Direct download  
     
    Export citation  
     
    Bookmark   6 citations  
  2.  21
    Ethical Advocacy Across the Autism Spectrum: Beyond Partial Representation.Matthew S. McCoy, Emily Y. Liu, Amy S. F. Lutz & Dominic Sisti - 2020 - American Journal of Bioethics 20 (4):13-24.
    Recent debates within the autism advocacy community have raised difficult questions about who can credibly act as a representative of a particular population and what responsibilities that...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   17 citations  
  3.  11
    On the Ethics of Vaccine Nationalism: The Case for the Fair Priority for Residents Framework.Ezekiel J. Emanuel, Allen Buchanan, Shuk Ying Chan, Cécile Fabre, Daniel Halliday, R. J. Leland, Florencia Luna, Matthew S. McCoy, Ole F. Norheim, G. Owen Schaefer, Kok-Chor Tan & Christopher Heath Wellman - 2021 - Ethics and International Affairs 35 (4):543-562.
    COVID-19 vaccines are likely to be scarce for years to come. Many countries, from India to the U.K., have demonstrated vaccine nationalism. What are the ethical limits to this vaccine nationalism? Neither extreme nationalism nor extreme cosmopolitanism is ethically justifiable. Instead, we propose the fair priority for residents framework, in which governments can retain COVID-19 vaccine doses for their residents only to the extent that they are needed to maintain a noncrisis level of mortality while they are implementing reasonable public (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4.  17
    Patient‐Engaged Research: Choosing the “Right” Patients to Avoid Pitfalls.Emily A. Largent, Holly Fernandez Lynch & Matthew S. McCoy - 2018 - Hastings Center Report 48 (5):26-34.
    Direct download  
     
    Export citation  
     
    Bookmark   5 citations  
  5.  32
    National Standards for Public Involvement in Research: Missing the Forest for the Trees.Matthew S. McCoy, Karin Rolanda Jongsma, Phoebe Friesen, Michael Dunn, Carolyn Plunkett Neuhaus, Leah Rand & Mark Sheehan - 2018 - Journal of Medical Ethics 44 (12):801-804.
    Biomedical research funding bodies across Europe and North America increasingly encourage—and, in some cases, require—investigators to involve members of the public in funded research. Yet there remains a striking lack of clarity about what ‘good’ or ‘successful’ public involvement looks like. In an effort to provide guidance to investigators and research organisations, representatives of several key research funding bodies in the UK recently came together to develop the National Standards for Public Involvement in Research. The Standards have critical implications for (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  6.  8
    Public Involvement in the Governance of Population-Level Biomedical Research: Unresolved Questions and Future Directions.Sonja Erikainen, Phoebe Friesen, Leah Rand, Karin Jongsma, Michael Dunn, Annie Sorbie, Matthew McCoy, Jessica Bell, Michael Burgess, Haidan Chen, Vicky Chico, Sarah Cunningham-Burley, Julie Darbyshire, Rebecca Dawson, Andrew Evans, Nick Fahy, Teresa Finlay, Lucy Frith, Aaron Goldenberg, Lisa Hinton, Nils Hoppe, Nigel Hughes, Barbara Koenig, Sapfo Lignou, Michelle McGowan, Michael Parker, Barbara Prainsack, Mahsa Shabani, Ciara Staunton, Rachel Thompson, Kinga Varnai, Effy Vayena, Oli Williams, Max Williamson, Sarah Chan & Mark Sheehan - 2021 - Journal of Medical Ethics 47 (7):522-525.
    Population-level biomedical research offers new opportunities to improve population health, but also raises new challenges to traditional systems of research governance and ethical oversight. Partly in response to these challenges, various models of public involvement in research are being introduced. Yet, the ways in which public involvement should meet governance challenges are not well understood. We conducted a qualitative study with 36 experts and stakeholders using the World Café method to identify key governance challenges and explore how public involvement can (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  7. What Are the Obligations of Pharmaceutical Companies in a Global Health Emergency?Ezekiel Emanuel, Allen Buchanan, Shuk Ying Chan, Fabre Cecile, Daniel Halliday, Joseph Heath, Lisa Maria Herzog, R. J. Leland, Matthew McCoy, Ole F. Norheim, Carla Saenz, G. Owen Schaefer, Kok-Chor Tan, Christopher Heath Wellman, Jonathan Wolff & Govind Persad - 2021 - Lancet 398 (10304):1015–1020.
    All parties involved in researching, developing, manufacturing, and distributing COVID-19 vaccines need guidance on their ethical obligations. We focus on pharmaceutical companies' obligations because their capacities to research, develop, manufacture, and distribute vaccines make them uniquely placed for stemming the pandemic. We argue that an ethical approach to COVID-19 vaccine production and distribution should satisfy four uncontroversial principles: optimising vaccine production, including development, testing, and manufacturing; fair distribution; sustainability; and accountability. All parties' obligations should be coordinated and mutually consistent. For (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  8.  8
    Patient and Public Involvement: Two Sides of the Same Coin or Different Coins Altogether?Matthew S. McCoy, Jonathan Warsh, Leah Rand, Michael Parker & Mark Sheehan - 2019 - Bioethics 33 (6):708-715.
    Direct download  
     
    Export citation  
     
    Bookmark   3 citations  
  9.  9
    A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.John H. Brems & Matthew S. McCoy - forthcoming - Ajob Empirical Bioethics:1-7.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  10.  15
    2017 Richard G. Condon Prize Essay “I Will Not Die on This Street:” Thinking Things Over in Conflicted Belfast.Matthew McCoy - 2018 - Ethos: Journal of the Society for Psychological Anthropology 46 (4):421-439.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  11.  13
    The Cratylus: Plato's Critique of Naming.Matthew K. McCoy - 1994 - Review of Metaphysics 47 (4):798-799.
    The three stated goals of this book are to provide an interpretation of the Cratylus which determines the roles Hermogenes and Cratylus play in the argument; to do justice to the dialogue's etymologies; and to assess the value of its aporetic conclusions. Baxter succeeds in presenting the dialogue, with its seemingly divergent parts, as a well-constructed whole. Baxter's interpretation enables the reader to raise the same kind of interpretive, philosophical questions that arise when one reads Plato's more accessible dialogues.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark